Veileder om bruk og nytte av periodisert regnskapsinformasjon i styringen - 3. Vurdering av ambisjonsnivå | DFØ
![PDF) Comparison of palonosetron with ondansetron, with respect to clinical efficacy and cost effectiveness in the prevention of chemotherapy induced nausea and vomiting in cancer patients PDF) Comparison of palonosetron with ondansetron, with respect to clinical efficacy and cost effectiveness in the prevention of chemotherapy induced nausea and vomiting in cancer patients](https://i1.rgstatic.net/publication/277312548_Comparison_of_palonosetron_with_ondansetron_with_respect_to_clinical_efficacy_and_cost_effectiveness_in_the_prevention_of_chemotherapy_induced_nausea_and_vomiting_in_cancer_patients/links/55673c7d08aec2268300f956/largepreview.png)
PDF) Comparison of palonosetron with ondansetron, with respect to clinical efficacy and cost effectiveness in the prevention of chemotherapy induced nausea and vomiting in cancer patients
![Evaluering av medisinske metoder – kan vi stole på kostnad-effekt-analyser? | Tidsskrift for Den norske legeforening Evaluering av medisinske metoder – kan vi stole på kostnad-effekt-analyser? | Tidsskrift for Den norske legeforening](https://tidsskriftet.no/sites/default/files/styles/default_scale/public/2003--L03-05-Med-19-001.jpg?itok=BH_wFr5v)